| 注册
首页|期刊导航|时珍国医国药|《伤寒论》桃花汤赤石脂"半全半末"配伍理论发微

《伤寒论》桃花汤赤石脂"半全半末"配伍理论发微

郭妹冉 梁绿圆 由笑蕊 丁雪颖 马丙祥

时珍国医国药2026,Vol.37Issue(10):1928-1933,6.
时珍国医国药2026,Vol.37Issue(10):1928-1933,6.DOI:10.70976/j.1008-0805.SZGYGY-2026-1019

《伤寒论》桃花汤赤石脂"半全半末"配伍理论发微

Elucidation of half-whole and half-powder compatibility theory of Halloysitum Rubrum in Taohua Decoction(桃花汤)from the Treatise on Febrile Diseases(伤寒论)

郭妹冉 1梁绿圆 2由笑蕊 3丁雪颖 3马丙祥2

作者信息

  • 1. 河北中医药大学,河北 石家庄 050091
  • 2. 河南中医药大学第一附属医院儿科医院,河南 郑州 450099||河南中医药大学儿科医学院,河南 郑州 450046
  • 3. 河南中医药大学儿科医学院,河南 郑州 450046
  • 折叠

摘要

Abstract

Documented by ZHANG Zhongjing as a classical formula for treating yin-cold diarrhea with purulent-bloody stool in Shaoyin Syndrome,Taohua Decoction(桃花汤)embodies unique formulation wisdom through Halloysitum Rubrum's divided preparation(half whole,half powdered).This study traces the textual origins in Sections 306-307 of the Treatise on Febrile Diseases(伤寒论)to analyze the compatibility mechanism of"dividing one jin(≈500 g)for dual application"of Halloysitum Rubrum.It examines the methodological principles through historical debates on pathomechanism interpretation,while systematically organizing four theoretical frameworks from ancient and modern physicians:Ascend-Descend Regulation and Pathogen Interception,Qi-Blood Layer Differentiation,Bodily Form and Functional Qi Management,and Concurrent Management of Root and Manifestation.Furthermore,it investigates contemporary clini-cal applications and translational values of this preparation approach,aiming to promote the inheritance and innovation of ZHANG Zhongjing's formulation wisdom while establishing a methodological paradigm for contemporary transformation of classical formulas.

关键词

《伤寒论》/桃花汤/赤石脂/半全半末

Key words

Treatise on Febrile Diseases(伤寒论)/Taohua Decoction(桃花汤)/Halloysitum Rubrum/Half-whole,half powder

分类

医药卫生

引用本文复制引用

郭妹冉,梁绿圆,由笑蕊,丁雪颖,马丙祥..《伤寒论》桃花汤赤石脂"半全半末"配伍理论发微[J].时珍国医国药,2026,37(10):1928-1933,6.

基金项目

国家自然科学基金(81973904) (81973904)

河南省特色骨干学科中医学学科建设项目(STG-ZYX06-202144,STG-ZYXKY-2020023) (STG-ZYX06-202144,STG-ZYXKY-2020023)

2023年度河南省中医学"双一流"创建科学研究专项课题(HSRP-DFCTCM-2023-3-06,HSRP-DFCTCM-2023-2-08) (HSRP-DFCTCM-2023-3-06,HSRP-DFCTCM-2023-2-08)

时珍国医国药

1008-0805

访问量0
|
下载量0
段落导航相关论文